Expanding and strengthening the Clinical Translational Research Center (RCTR) at Meharry (MeTRC) represents our overall goal of enhancing translational research involving health disparities with an overarching goal of improving the overall health of the underserved in particularly, and the overall population, in general. The MeTRC was established in 2009 under the U54 funding mechanism from the former NCRR/NIH. When NCRR was closed at the end of 2011, the RCTR Program was transferred under the RCMI Program to the NIMHD. During the first funding cycle (2009-2014) the MeTRC leadership established the infrastructure for the RCTR at Meharry Medical College (MMC). MeTRC has successfully accomplished this goal. In the current application, our challenge is to strengthen and enhance our translational research enterprise and increase our capability to compete for mainstream extramural funding consistent with a mission driven by our motivation to eliminate health disparities and barriers to care for minorities and the underserved. This RCTR program also offers a clear opportunity for MMC to enhance and strengthen clinical and translational research in health disparities areas including, but not limited to, inflammatory/infectious diseases, diabetes, cardiovascular diseases, mental health disorders and cancer that significantly impact on the health of our minority and underserved population. The RCTR initiative also provides MMC with an excellent opportunity to demonstrate its role in clinical translational research in health disparities relevant to the overall goal of improving the health and healthcare of the entire population. In this endeavor, MeTRC's clear overarching goals are 1) focus on health disparities research as indicated above; 2) link basic science research with clinical and population science research by promoting and strengthening the T1/T2/T3/T4 translational research continuum that enhances synergy; 3) promote both internal and external collaborations and partnership (i.e. with the RTRN institutions and Vanderbilt-Meharry CTSA) and, 4) support highly competitive translational research projects promoted by trans-disciplinary collaborative team science approach models. In the current application, the Administrative Core's specific aims are to 1) efficiently manage the RCTR budget, 2) insure efficient administrative oversight and adequate communication between RCTR components and NIMHD, 3) set programmatic goals and manage assessment processes to assure productivity and progress, and 4) coordinate RCTR functions and activities/cores. We propose to achieve our specific aims through integrated and collaborative efforts supported by four mandatory and eight optional Activities/Cores described in this application. The role of the Administrative Core is to provide dynamic and efficient administrative leadership, supervise the entire RCTR program in compliance with federal regulations and policies and implement the programmatic goals of the center. This core will also provide an effective oversight and coordinate the functions/activities of the various cores, and oversee implementation of the budget. The core is also responsible for coordinating evaluation of the program, monitoring progress, reporting progress to the NIH and maintaining strong interaction with the NIMHD/NIH Program Director(s) in accordance with the U54 mechanism.

Public Health Relevance

The Administrative core has the overall responsibility for ensuring that RCTR-funded research is carried out in compliance with relevant federal regulations and policies. This core is directed by the Program Director/ Principal Investigator (PD/PI) with the assistance of members of the Administrative/Governance team. The main function of the Administrative Core is to manage, coordinate and supervise the entire array of RCTR programmatic functions/activities that are carried out in all the cores. Other critical functions of this core are to ensure efficient and effective implementation of all activities, coordinate evaluation of the program, and monitor progress and report annual progress to NIH. This core is also responsible for maintaining strong interaction with the NIMHD/NIH Program Director(s) as mandated by the terms and conditions of the U54 corporative agreement between the NIH and MMC. Thus, the functional role of this core will significantly impact on the success of our RCTR Program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MD007593-10
Application #
9471260
Study Section
Special Emphasis Panel (ZMD1)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Meharry Medical College
Department
Type
DUNS #
041438185
City
Nashville
State
TN
Country
United States
Zip Code
37208
Ho, Meng-Hsuan; Lamont, Richard J; Chazin, Walter J et al. (2018) Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis. Mol Oral Microbiol 33:430-439
Dash, Sabyasachi; Balasubramaniam, Muthukumar; Dash, Chandravanu et al. (2018) Biotin-based Pulldown Assay to Validate mRNA Targets of Cellular miRNAs. J Vis Exp :
Ochieng, Josiah; Nangami, Gladys; Sakwe, Amos et al. (2018) Impact of Fetuin-A (AHSG) on Tumor Progression and Type 2 Diabetes. Int J Mol Sci 19:
Cheatham, Amber M; Davis, Shamara E; Khatua, Atanu K et al. (2018) Blocking the 5' splice site of exon 4 by a morpholino oligomer triggers APOL1 protein isoform switch. Sci Rep 8:8739
Dong, Xin-Hong; Ho, Meng-Hsuan; Liu, Bindong et al. (2018) Role of Porphyromonas gingivalis outer membrane vesicles in oral mucosal transmission of HIV. Sci Rep 8:8812
Burroughs, Andrea Flores; Eluhu, Sylvia; Whalen, Diva et al. (2018) PML-Nuclear Bodies Regulate the Stability of the Fusion Protein Dendra2-Nrf2 in the Nucleus. Cell Physiol Biochem 47:800-816
Suman, Shankar; Rachakonda, Girish; Mandape, Sammed N et al. (2018) Phospho-proteomic analysis of primary human colon epithelial cells during the early Trypanosoma cruzi infection phase. PLoS Negl Trop Dis 12:e0006792
Balasubramaniam, Muthukumar; Zhou, Jing; Addai, Amma et al. (2018) PF74 Inhibits HIV-1 Integration by Altering The Composition of the Preintegration Complex. J Virol :
Boyer, Alaina P; Fair, Alecia M; Joosten, Yvonne A et al. (2018) A Multilevel Approach to Stakeholder Engagement in the Formulation of a Clinical Data Research Network. Med Care 56 Suppl 10 Sup:S22-S26
Huderson, Ashley C; Rekha Devi, P V; Niaz, Mohammad S et al. (2018) Alteration of benzo(a)pyrene biotransformation by resveratrol in Apc Min/+ mouse model of colon carcinogenesis. Invest New Drugs :

Showing the most recent 10 out of 164 publications